Identifying more strongly associated variants with ovarian cancer in the 9p22.2 region relative to the initial GWAS hit in BRCA1 and BRCA2 mutation carriers will refine the cancer risks associated with this locus further. The gene discussed is BRCA1; the disease is ovarian cancer.